Seeking Alpha

Bio-Reference Labs (BRLI +6.5%) pops after BofA Merrill Lynch ups the shares to Buy, citing how...

Bio-Reference Labs (BRLI +6.5%) pops after BofA Merrill Lynch ups the shares to Buy, citing how the returns on the commercialization of its high-end tests in a number of high-growth specialty niches are starting to bear fruit. Additionally, reimbursement headwinds and new billing codes are more likely to disproportionately impact small players, which gives BRLI the opportunity to capture market share.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)